Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug registration application in China.

Li Hui Zhen1

  • 1International Medical and Commercial College, China Pharmaceutical University, NanJing, China. lihuizhenCPU@hotmail.com

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques
|August 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug control authorities in China.

The Annals of pharmacotherapyยท2004
See all related articles

This guide provides an overview of China's drug registration application process, detailing requirements for applicants and outlining the review procedures for pharmaceuticals. It ensures safe and effective drug availability for Chinese citizens.

Area of Science:

  • Pharmaceutical Regulatory Affairs
  • International Drug Registration
  • Chinese Pharmaceutical Market

Background:

  • Understanding the evolving landscape of drug registration is crucial for pharmaceutical companies.
  • Navigating international regulatory requirements presents significant challenges.
  • China's growing pharmaceutical market necessitates specific registration knowledge.

Purpose of the Study:

  • To provide a comprehensive overview of the drug registration application process in China.
  • To offer insights for international stakeholders seeking to understand China's regulatory framework.
  • To highlight key considerations for submitting pharmaceutical applications in China.

Main Methods:

  • Detailed description of new elements in the current drug registration application.

Related Experiment Videos

  • Explanation of applicant qualifications and registration classifications.
  • Outline of the review process, intellectual property rights, submission procedures, and required documentation.

    • Main Results:

    • Gained comprehensive knowledge of the drug registration application process in China.
    • Clarified the requirements for pharmaceutical product registration.
    • Provided a foundational understanding for successful application submissions.

    Conclusions:

    • China's current drug registration provisions are aligned with international standards (WTO entry).
    • The regulatory framework ensures the availability of safe and effective drugs for the Chinese population.
    • The updated provisions support both domestic and international pharmaceutical development.